EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

2019: A year of expansion in psychedelic research, industry, and deregulation

Jacob S Aday, Emily K Bloesch, Christopher C Davoli

Drug Science, Policy and Law · 2020-01 · 6

DOI: 10.1177/2050324520974484 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Science, Policy and Law, online erschienen am 25.11.2020. Verfasst von Jacob S Aday und 2 weiteren Autor:innen. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Public and scientific interest into psychedelic drugs has grown steadily over much of the last two decades, before an exponential increase in recent years. We contend that 2019, in particular, involved myriad notable changes in the science, industry, and deregulation of psychedelic drugs. However, it is becoming increasingly difficult for professionals to keep up-to-date on these advancements given the rapid growth of the field. Further, broad contemporary synopses are critical in maintaining records in the history of science. To address these concerns, this article synthesizes the significant number of scientific, business, and regulatory changes related to psychedelic drugs which occurred in 2019. Establishment of psychedelic research centers, novel applications of the drugs, and international expansion of the field in 2019 seemed to solidify psychedelic research’s place in science. Additionally, many in the business and pharmaceutical industries stimulated considerable investment and innovation in psychedelics for the first time. In the US, successful decriminalization efforts and endorsements by eminent political figures, such as Alexandria Ocasio-Cortez, Andrew Yang, and the heads of the NIH and FDA, in 2019 were representative of unprecedented regulatory changes. Collectively, this article serves as a succinct summary of the changes psychedelic drugs made across various levels of society in 2019—by coalescing emerging research themes, industrial innovations, and attitude shifts.

Zitieren

APA

Aday, J. S., Bloesch, E. K., & Davoli, C. C. (2020). 2019: A year of expansion in psychedelic research, industry, and deregulation. Drug Science, Policy and Law, 6. https://doi.org/10.1177/2050324520974484

Vancouver

Aday JS, Bloesch EK, Davoli CC. 2019: A year of expansion in psychedelic research, industry, and deregulation. Drug Science, Policy and Law. 2020;6. doi:10.1177/2050324520974484

BibTeX
@article{Aday2020,
  author = {Aday, Jacob S and Bloesch, Emily K and Davoli, Christopher C},
  title = {2019: A year of expansion in psychedelic research, industry, and deregulation},
  journal = {Drug Science, Policy and Law},
  year = {2020},
  volume = {6},
  doi = {10.1177/2050324520974484}
}
Kostenlos starten →